Solid Biosciences Inc.
Income Statement
| Line Item | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 | Sep 2019 | Jun 2019 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | $15.7M | $16.0M | $13.4M | $19.7M | $27.1M | $22.8M | $21.6M | $23.3M |
| SG&A Expense | $5.6M | $5.2M | $5.5M | $5.3M | $5.3M | $6.9M | $5.4M | $7.0M |
| Operating Income | $-21.3M | $-21.2M | $-19.0M | $-26.9M | $-32.3M | $-29.7M | $-27.0M | $-30.3M |
| Operating Margin | — | — | — | — | — | — | — | — |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | $-21.4M | $-21.2M | $-19.0M | $-26.7M | $-31.9M | $-29.3M | $-26.5M | $-29.6M |
| Net Margin | — | — | — | — | — | — | — | — |
| EPS (Basic) | $-1.51 | $-0.03 | $-0.02 | $-0.04 | $-0.04 | $-0.04 | $-0.05 | $-0.05 |
| EPS (Diluted) | $-1.51 | $-0.03 | $-0.02 | $-0.04 | $-0.04 | $-0.04 | $-0.05 | $-0.05 |
| Shares Outstanding (Basic) | 1.36B | 738.9M | 735.8M | 737.1M | 735.8M | 736.0M | 566.4M | 566.6M |
| Shares Outstanding (Diluted) | 1.36B | 738.9M | 735.8M | 737.1M | 735.8M | 736.0M | 566.4M | 566.6M |
| Dividends Per Share | — | — | — | — | — | — | — | — |